Humacyte Inc Warrant
HUMAW
HUMAW was delisted on the 25th of August, 2026.
9 hedge funds and large institutions have $573K invested in Humacyte Inc Warrant in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.
13% more funds holding
Funds holding: 8 → 9 (+1)
0.05% less ownership
Funds ownership: 0.88% → 0.84% (-0.05%)
13% less capital invested
Capital invested by funds: $660K → $573K (-$86.3K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
+$9.37K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$610 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$17K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$14.9K |
| 3 |
JAIC
Josh Arnold Investment Consultant
Edina,
Minnesota
|
-$12.9K |
| 4 |
Jane Street
New York
|
-$1.41K |
HUMAW Hedge Fund Activity: Q3 2023 in Review
9 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q3 2023, worth a combined $573K — down 13% from $660K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new HUMAW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.
The largest buyer was LPL Financial, adding an estimated $9.37K. The largest seller was Walleye Capital, cutting an estimated $17K.
- 9 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q3 2023, up from 8 in Q2 2023.
- Funds reported $573K of Humacyte Inc Warrant stock for Q3 2023, down 13% quarter-over-quarter.
- 1 fund opened new Humacyte Inc Warrant positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Humacyte Inc Warrant buyer in Q3 2023 was LPL Financial, an estimated $9.37K added.
- The largest Humacyte Inc Warrant seller in Q3 2023 was Walleye Capital, an estimated $17K sold.
Based on aggregated 13F filings for Q3 2023.